New Obesity Treatments Offer Hope Beyond Weight Loss

Obesity is a significant public health crisis in Israel, with nearly 60% of adults and one-third of adolescents overweight or obese. This condition is not merely an aesthetic concern but a major risk factor for morbidity and premature mortality, with long-term health consequences. Professor Itamar Raz, chairman of the Scientific Council for the Prevention and Treatment of Obesity and Diabetes, describes it as a "plague" that requires a comprehensive national plan to address its health, economic, and social impacts. He highlights disparities in access to treatment, nutrition, and health education between Israel's center and periphery.

Raz emphasizes that obesity is a biological disease, not a matter of willpower, and advocates for a national strategy similar to that used for diabetes, involving resource allocation, coordinated efforts, practical measures like product labeling, and data-driven approaches. He notes that recent medical advancements have expanded treatment options, with new medications now available, some covered by the national health basket for individuals aged 12 and older. These treatments, when combined with medical supervision and lifestyle changes, can aid in managing obesity and related conditions.

Professor Dror Dicker, chairman of the Israeli Society for the Study and Treatment of Obesity, counters the common perception of obesity as a choice, defining it as a physiological failure. He explains that imbalances in hunger and satiety hormones can lead to excessive calorie intake and weight gain, making lifestyle changes alone an unrealistic solution. Dicker strongly objects to the term "weight loss injections," arguing that it shifts focus solely to weight, overshadowing the treatments' profound health benefits. These benefits include reducing inflammation, liver fibrosis, heart dysfunction mortality, and sleep apnea, stemming from the reduction of excess body fat.

Dicker warns that an overemphasis on weight can lead to inappropriate treatment requests for cosmetic reasons and premature discontinuation of therapy by those who reach a "target weight." He stresses the importance of multidisciplinary care, including nutritional counseling, physical activity, and psychosocial support, to prevent weight regain. Professor Raz concurs, noting that patient disappointment with the pace of weight loss can lead to treatment cessation, and that managing expectations is crucial, as responses vary and weight can be regained even after reaching a goal weight. He also points out potential side effects of medications, such as nausea and diarrhea, which are usually temporary and manageable with medical guidance. Both professors advocate for synchronized medical, educational, economic, and social action to combat the obesity epidemic, which will be a central theme at TheMarker Labels Obesity Conference on October 8th. Raz concludes optimistically that Israel can effectively tackle this epidemic with proper attention from decision-makers.